Related Experiment Video
Updated: Feb 16, 2026

Studying Interactions between Myeloid Cells and CAR T Cells In Vitro and In Vivo
Published on: July 25, 2025
The rate of spontaneous mutations in human myeloid cells
David J Araten1, Ondrej Krejci, Kimberly Ditata
1Division of Hematology, Department of Veterans Affairs New York Harbor Healthcare System, United States; Division of Hematology, Department of Medicine, NYU School of Medicine and the NYU Langone Cancer Center, United States.
Abstract:
The mutation rate (μ) is likely to be a key parameter in leukemogenesis, but historically, it has been difficult to measure in humans. The PIG-A gene has some advantages for the detection of spontaneous mutations because it is X-linked, and therefore only one mutation is required to disrupt its function. Furthermore, the PIG-A-null phenotype is readily detected by flow cytometry. Using PIG-A, we have now provided the first in vitro measurement of μ in myeloid cells, using cultures of CD34+ cells that are transduced with either the AML-ETO or the MLL-AF9 fusion genes and expanded with cytokines. For the AML-ETO cultures, the median μ value was ∼9.4×10(-7) (range ∼3.6-23×10(-7)) per cell division. In contrast, few spontaneous mutations were observed in the MLL-AF9 cultures. Knockdown of p53 or introduction of mutant NRAS or FLT3 alleles did not have much of an effect on μ. Based on these data, we provide a model to predict whether hypermutability must occur in the process of leukemogenesis.
Insights
Measuring the mutation rate (μ) in human myeloid cells is crucial for understanding leukemia. This study provides the first in vitro measurement of μ using the PIG-A gene, revealing insights into leukemogenesis.
Area of Science:
- Hematology
- Molecular Biology
- Genetics
Background:
- The mutation rate (μ) is a critical factor in leukemogenesis, but its measurement in human cells has been challenging.
- The PIG-A gene offers advantages for mutation detection due to its X-linked nature and a readily detectable null phenotype via flow cytometry.
Purpose of the Study:
- To provide the first in vitro measurement of the mutation rate (μ) in human myeloid cells.
- To investigate the role of specific fusion genes (AML-ETO, MLL-AF9) and genetic alterations in myeloid cell hypermutability during leukemogenesis.
Main Methods:
- Utilized CD34+ myeloid progenitor cells transduced with AML-ETO or MLL-AF9 fusion genes.
- Employed the PIG-A gene assay for in vitro detection of spontaneous mutations and measured mutation rates per cell division.
- Assessed the impact of p53 knockdown and mutations in NRAS or FLT3 on the mutation rate.
Main Results:
- The median mutation rate (μ) in AML-ETO-transduced cells was approximately 9.4×10⁻⁷ per cell division.
- MLL-AF9-transduced cells exhibited significantly fewer spontaneous mutations compared to AML-ETO cells.
- Modifications in p53, NRAS, or FLT3 showed minimal effect on the measured mutation rates.
Conclusions:
- This study establishes a method for measuring mutation rates in human myeloid cells, providing critical data for leukemogenesis research.
- The findings suggest that the AML-ETO fusion gene is associated with a higher mutation rate in myeloid cells, potentially contributing to leukemogenesis.
- A model is proposed to predict the necessity of hypermutability in the leukemogenesis process based on these experimental data.
Related Concept Videos
Spontaneous and Induced Mutations
Spontaneity
Viral Mutations
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Differentiation of Common Myeloid Progenitor Cells

